Exact Mass: 442.3658

Exact Mass Matches: 442.3658

Found 66 metabolites which its exact mass value is equals to given mass value 442.3658, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

DG(8:0/15:0/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl pentadecanoic acid

C26H50O5 (442.3658)


DG(8:0/15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/15:0)

[(2R)-2-hydroxy-3-octanoyloxypropyl] pentadecanoate

C26H50O5 (442.3658)


DG(8:0/0:0/15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/i-15:0/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl 13-methyltetradecanoic acid

C26H50O5 (442.3658)


DG(8:0/i-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/i-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/i-15:0)

[(2R)-2-hydroxy-3-octanoyloxypropyl] 13-methyltetradecanoate

C26H50O5 (442.3658)


DG(8:0/0:0/i-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/a-15:0/0:0)

(2S)-1-Hydroxy-3-(octanoyloxy)propan-2-yl 12-methyltetradecanoic acid

C26H50O5 (442.3658)


DG(8:0/a-15:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(8:0/a-15:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(8:0/0:0/a-15:0)

[(2R)-2-hydroxy-3-octanoyloxypropyl] 12-methyltetradecanoate

C26H50O5 (442.3658)


DG(8:0/0:0/a-15:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/13:0/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl tridecanoic acid

C26H50O5 (442.3658)


DG(10:0/13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/13:0)

[(2R)-3-decanoyloxy-2-hydroxypropyl] tridecanoate

C26H50O5 (442.3658)


DG(10:0/0:0/13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/i-13:0/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl 11-methyldodecanoic acid

C26H50O5 (442.3658)


DG(10:0/i-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/i-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/i-13:0)

[(2R)-3-decanoyloxy-2-hydroxypropyl] 11-methyldodecanoate

C26H50O5 (442.3658)


DG(10:0/0:0/i-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/a-13:0/0:0)

(2S)-1-(Decanoyloxy)-3-hydroxypropan-2-yl 10-methyldodecanoic acid

C26H50O5 (442.3658)


DG(10:0/a-13:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(10:0/a-13:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(10:0/0:0/a-13:0)

[(2R)-3-decanoyloxy-2-hydroxypropyl] 10-methyldodecanoate

C26H50O5 (442.3658)


DG(10:0/0:0/a-13:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/10:0/0:0)

[(2S)-2-decanoyloxy-3-hydroxypropyl] tridecanoate

C26H50O5 (442.3658)


DG(13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(13:0/0:0/10:0)

[(2S)-3-decanoyloxy-2-hydroxypropyl] tridecanoate

C26H50O5 (442.3658)


DG(13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/10:0/0:0)

(2S)-2-(decanoyloxy)-3-hydroxypropyl 11-methyldodecanoate

C26H50O5 (442.3658)


DG(i-13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-13:0/0:0/10:0)

(2S)-3-(decanoyloxy)-2-hydroxypropyl 11-methyldodecanoate

C26H50O5 (442.3658)


DG(i-13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/10:0/0:0)

[(2S)-2-decanoyloxy-3-hydroxypropyl] 10-methyldodecanoate

C26H50O5 (442.3658)


DG(a-13:0/10:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-13:0/10:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-13:0/0:0/10:0)

[(2S)-3-decanoyloxy-2-hydroxypropyl] 10-methyldodecanoate

C26H50O5 (442.3658)


DG(a-13:0/0:0/10:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl pentadecanoate

C26H50O5 (442.3658)


DG(15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(15:0/0:0/8:0)

(2S)-2-hydroxy-3-(octanoyloxy)propyl pentadecanoate

C26H50O5 (442.3658)


DG(15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl 13-methyltetradecanoate

C26H50O5 (442.3658)


DG(i-15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(i-15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(i-15:0/0:0/8:0)

[(2S)-2-hydroxy-3-octanoyloxypropyl] 13-methyltetradecanoate

C26H50O5 (442.3658)


DG(i-15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/8:0/0:0)

(2S)-3-hydroxy-2-(octanoyloxy)propyl 12-methyltetradecanoate

C26H50O5 (442.3658)


DG(a-15:0/8:0/0:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. DG(a-15:0/8:0/0:0) is also a substrate of diacylglycerol kinase. It is involved in the phospholipid metabolic pathway.

   

DG(a-15:0/0:0/8:0)

[(2S)-2-hydroxy-3-octanoyloxypropyl] 12-methyltetradecanoate

C26H50O5 (442.3658)


DG(a-15:0/0:0/8:0) belongs to the family of Diacylglycerols. These are glycerolipids lipids containing a common glycerol backbone to which at least one fatty acyl group is esterified. It is involved in the phospholipid metabolic pathway.

   
   
   

(20S)-20-(N,N-dimethylamino)-3beta-(N-senecoylamino)-5alpha-pregn-16-en-4beta-ol|hookerianamide J

(20S)-20-(N,N-dimethylamino)-3beta-(N-senecoylamino)-5alpha-pregn-16-en-4beta-ol|hookerianamide J

C28H46N2O2 (442.3559)


   

soalnopubamine A

soalnopubamine A

C28H46N2O2 (442.3559)


   
   
   

(2E,20S)-20-(dimethylamino)-2beta-hydroxy-3beta-(tigloylamino)pregn-14-ene|2-hydroxysalignamine-E|2-hydroxysalignarine-E

(2E,20S)-20-(dimethylamino)-2beta-hydroxy-3beta-(tigloylamino)pregn-14-ene|2-hydroxysalignamine-E|2-hydroxysalignarine-E

C28H46N2O2 (442.3559)


   
   

N-Formylcyclovirobuxeine B

N-Formylcyclovirobuxeine B

C28H46N2O2 (442.3559)


   
   

Stearoyl Serotonin

N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-octadecanamide

C28H46N2O2 (442.3559)


   

SA-5HT

N-[2-(5-hydroxy-1H-indol-3-yl)ethyl]-octadecanamide

C28H46N2O2 (442.3559)


   

Hookerianamide J

Hookerianamide J

C28H46N2O2 (442.3559)


A steroid alkaloid that is 5alpha-preg-16-ene substituted by a hydroxy group at position 4, a N,N-dimethylamino group at position 20 and a N-senecoylamino group at position 3 (the 3beta,4beta,20S stereoisomer). Isolated from Sarcococca hookeriana, it exhibits antileishmanial and antibacterial activities.

   

N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]octadecanamide

N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]octadecanamide

C28H46N2O2 (442.3559)


   

(1-Heptanoyloxy-3-hydroxypropan-2-yl) hexadecanoate

(1-Heptanoyloxy-3-hydroxypropan-2-yl) hexadecanoate

C26H50O5 (442.3658)


   

(1-Hydroxy-3-nonanoyloxypropan-2-yl) tetradecanoate

(1-Hydroxy-3-nonanoyloxypropan-2-yl) tetradecanoate

C26H50O5 (442.3658)


   

(1-Decanoyloxy-3-hydroxypropan-2-yl) tridecanoate

(1-Decanoyloxy-3-hydroxypropan-2-yl) tridecanoate

C26H50O5 (442.3658)


   

(1-Hydroxy-3-undecanoyloxypropan-2-yl) dodecanoate

(1-Hydroxy-3-undecanoyloxypropan-2-yl) dodecanoate

C26H50O5 (442.3658)


   

(1-Butanoyloxy-3-hydroxypropan-2-yl) nonadecanoate

(1-Butanoyloxy-3-hydroxypropan-2-yl) nonadecanoate

C26H50O5 (442.3658)


   

(1-Hydroxy-3-propanoyloxypropan-2-yl) icosanoate

(1-Hydroxy-3-propanoyloxypropan-2-yl) icosanoate

C26H50O5 (442.3658)


   

(1-Hydroxy-3-octanoyloxypropan-2-yl) pentadecanoate

(1-Hydroxy-3-octanoyloxypropan-2-yl) pentadecanoate

C26H50O5 (442.3658)


   

(1-Hydroxy-3-pentanoyloxypropan-2-yl) octadecanoate

(1-Hydroxy-3-pentanoyloxypropan-2-yl) octadecanoate

C26H50O5 (442.3658)


   

(1-Acetyloxy-3-hydroxypropan-2-yl) henicosanoate

(1-Acetyloxy-3-hydroxypropan-2-yl) henicosanoate

C26H50O5 (442.3658)


   

(1-Hexanoyloxy-3-hydroxypropan-2-yl) heptadecanoate

(1-Hexanoyloxy-3-hydroxypropan-2-yl) heptadecanoate

C26H50O5 (442.3658)


   

[(2S)-3-hydroxy-2-undecanoyloxypropyl] dodecanoate

[(2S)-3-hydroxy-2-undecanoyloxypropyl] dodecanoate

C26H50O5 (442.3658)


   

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] dodecanoate

[(2S)-1-hydroxy-3-undecanoyloxypropan-2-yl] dodecanoate

C26H50O5 (442.3658)


   

DG 10:0_13:0

DG 10:0_13:0

C26H50O5 (442.3658)


   

DG 11:0_12:0

DG 11:0_12:0

C26H50O5 (442.3658)


   
   

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-methylbut-2-enimidic acid

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

n-{18-hydroxy-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracosan-7-yl}carboximidic acid

n-{18-hydroxy-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracosan-7-yl}carboximidic acid

C28H46N2O2 (442.3559)


   

n-{1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-methylbut-2-enimidic acid

n-{1-[1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-3-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

(2e)-n-[(1s,3as,3bs,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

(2e)-n-[(1s,3as,3bs,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

3-[(3-hydroxydecanoyl)oxy]hexadecanoic acid

3-[(3-hydroxydecanoyl)oxy]hexadecanoic acid

C26H50O5 (442.3658)


   

n-[(3as,3br,5ar,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid

n-[(3as,3br,5ar,6r,7s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-6-hydroxy-9a,11a-dimethyl-3h,3ah,3bh,4h,5h,5ah,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

(2e)-n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

(2e)-n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

n-[(1s,2r,5s,7s,10s,11s,14s,15r,16s,17r,18s,20s,23s)-18-hydroxy-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracosan-7-yl]carboximidic acid

n-[(1s,2r,5s,7s,10s,11s,14s,15r,16s,17r,18s,20s,23s)-18-hydroxy-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.0²,¹¹.0⁵,¹⁰.0¹⁵,²³.0¹⁷,²²]tetracosan-7-yl]carboximidic acid

C28H46N2O2 (442.3559)


   

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-2-methylbut-2-enimidic acid

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,5h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

(2e)-n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

(2e)-n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid

n-[(1s,3as,3bs,7r,8s,9ar,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl]-3-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-2-methylbut-2-enimidic acid

n-{1-[1-(dimethylamino)ethyl]-8-hydroxy-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-yl}-2-methylbut-2-enimidic acid

C28H46N2O2 (442.3559)


   

(1s,6s,8r,14r,21s)-8,21-dimethyl-10,23-diazapentacyclo[17.7.1.1⁶,¹⁰.0²³,²⁷.0¹⁴,²⁸]octacosane-7,20-dione

(1s,6s,8r,14r,21s)-8,21-dimethyl-10,23-diazapentacyclo[17.7.1.1⁶,¹⁰.0²³,²⁷.0¹⁴,²⁸]octacosane-7,20-dione

C28H46N2O2 (442.3559)